Orchestra BioMed Holdings, Inc. Gain (Loss) on Extinguishment of Debt
Orchestra BioMed Holdings, Inc. (OBIO) reported Gain (Loss) on Extinguishment of Debt of -$1.15 million for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2025-03-31
- Orchestra BioMed Holdings, Inc. gain (loss) on extinguishment of debt for the quarter ending 2023-03-31 was $682.00K.
- Orchestra BioMed Holdings, Inc. gain (loss) on extinguishment of debt for the quarter ending 2022-12-31 was $0.00.
- Orchestra BioMed Holdings, Inc. gain (loss) on extinguishment of debt for the quarter ending 2022-09-30 was $0.00.
- Orchestra BioMed Holdings, Inc. gain (loss) on extinguishment of debt for the quarter ending 2022-06-30 was -$682.00K.
- Orchestra BioMed Holdings, Inc. gain (loss) on extinguishment of debt for fiscal 2023 was -$1.15M.
- Orchestra BioMed Holdings, Inc. gain (loss) on extinguishment of debt for fiscal 2022 was -$682.00K.
| Period end | Gain (Loss) on Extinguishment of Debt 3 month | Gain (Loss) on Extinguishment of Debt 6 month | Gain (Loss) on Extinguishment of Debt 9 month | Gain (Loss) on Extinguishment of Debt 12 month |
|---|---|---|---|---|
| 2023-12-31 | -$1.15M 10-K · filed 2025-03-31 | |||
| 2023-03-31 | $682.00K 10-Q · filed 2023-05-12 | $682.00K derived: sum of 2 quarters · filed 2024-03-27 | $682.00K derived: sum of 3 quarters · filed 2024-03-27 | $0.00 derived: sum of 4 quarters · filed 2024-03-27 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $0.00 derived: sum of 2 quarters · filed 2024-03-27 | -$682.00K derived: sum of 3 quarters · filed 2024-03-27 | -$682.00K 10-K · filed 2024-03-27 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$682.00K derived: sum of 2 quarters · filed 2023-11-13 | -$682.00K 10-Q · filed 2023-11-13 | |
| 2022-06-30 | -$682.00K 10-Q · filed 2023-08-10 | -$682.00K 10-Q · filed 2023-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |